Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of JMKX003142 in Hepatic Impairment
NCT07909070Phase 1Not yet recruiting
- Sponsor
- Jemincare
- Start
- Nov 2026
- Primary completion
- May 2027
01
Overview
Phase 1, open-label trial of JMKX003142 in autosomal dominant polycystic kidney disease (ADPKD) and renal edema (3 cohorts), sponsored by Jemincare. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-Time Curve From Time Zero to Time of Last Quantifiable Concentration and 4 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
JMKX003142
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)renal edema
Beyond the preview
Go deeper on NCT07909070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07909070.